Skip to content

What a successful insurance appeal campaign looks like

A denial letter usually starts a process with several stages, deadlines and an independent review at the end. What a well-run appeal includes, and why so few people use the steps available to them.

Updated Sep 26, 2026Evidence-backed

A denial letter can feel final, but it usually isn't. Insurance appeals have several stages, each with its own deadline, and the last one is decided by a reviewer outside your insurer. It helps to treat the appeal as a small project with documents, dates and follow-up. This guide builds on our FAQ My insurance denied coverage. What now?

Most denials are never appealed

KFF's analysis of HealthCare.gov marketplace plans found that insurers denied 19% of in-network claims in 2024, and fewer than 1% of denied in-network claims were appealed. When people did file an internal appeal, insurers upheld their original decision 66% of the time, which means about a third were overturned (KFF, March 2026 (external link)). Many people don't know the later steps exist: in a 2023 KFF survey, only 40% of consumers believed they had a legal right to appeal to a government agency or independent medical expert, and 51% weren't sure. Those figures come from marketplace plans; employer plans publish much less data.

The typical stages

  1. Find the exact denial reason. Denials cite a specific code or explanation, such as "not medically necessary," "step therapy not completed" or "excluded benefit." Your appeal has to answer that reason. A generic letter that ignores it is far less likely to work.
  2. File a first-level internal appeal. You have 180 days from the denial to file (healthcare.gov (external link)). Your prescriber sends the documentation that answers the denial reason: clinical notes, BMI and comorbidity history, prior treatments. The plan must decide within 30 days for a drug you haven't received yet, or faster if your health requires it.
  3. Use a second internal level if your plan has one. Some plans add a second internal review, sometimes by a different reviewer or medical director, before external review opens up.
  4. Ask for external review. If the internal appeal fails, you can ask for an independent review by an organization not tied to your insurer. You have 4 months from the final internal decision to request it, and your insurer is legally required to accept the reviewer's decision (healthcare.gov (external link)). Very few people get this far: KFF counted at least 5,881 external appeals from marketplace enrollees in 2024, about 4% of upheld internal appeals. Our guide on escalation paths beyond your insurer covers this and other outside options.

What gives an appeal its best chance

These are practical tips, not findings from a study. Answer the stated denial reason point by point instead of restating general medical need (see how to write an appeal letter). Back it with specific clinical documentation: lab values, BMI history, comorbidity diagnoses and prior treatments. A general letter of support on its own gives the reviewer much less to work with.

Keep track of every deadline, because appeal windows are strict and missing one can cost you the right to go further. If the first level fails, go to the next one; a denied internal appeal still leaves external review, and almost no one uses it. It also helps to have a prescriber's office that knows the process. Practices that handle GLP-1 prior authorizations and appeals regularly often know what documentation a given insurer or PBM responds to.

This article is general education, not medical, legal, or insurance advice. Coverage rules, appeal rights, and policy details vary by plan and location and change over time. Confirm specifics with your plan, prescriber, or a qualified advisor.

appealsadvocacyinsurance

Was this helpful?

Common questions

Questions people often ask about this topic.

  • Is an insurance denial final?

    Usually not. Appeals have several stages: a first-level internal appeal, sometimes a second internal level, and then an independent external review. Very few people use them. In HealthCare.gov marketplace plans, fewer than 1% of denied in-network claims were appealed in 2024, and about a third of internal appeals that were filed ended with the denial overturned.

  • What are the typical stages of an appeal?

    First, find the specific denial reason (such as "not medically necessary" or "step therapy not completed"). Then file a first-level internal appeal within 180 days, with your prescriber's documentation answering that reason. Some plans add a second internal level. If the internal appeal fails, you have 4 months to request an independent external review, and your insurer must accept that decision.

  • What makes an appeal more likely to succeed?

    As practical advice: answer the stated denial reason point by point instead of restating general medical need, include specific clinical documentation such as lab values, BMI history, comorbidities and prior treatments, meet every deadline, and move to the next level, including external review, if an earlier one fails.

  • Does it matter how experienced my doctor's office is with appeals?

    It can help. Practices that handle GLP-1 prior authorizations and appeals regularly often know what documentation a given insurer or PBM responds to.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

3Supporting

  • Claims Denials and Appeals in ACA Marketplace Plans in 2024 (external link)

    KFF · Reporting · Strong evidence

    (2026)

    Published March 24, 2026. HealthCare.gov insurers denied 19% of in-network claims in 2024; fewer than 1% of denied in-network claims were appealed; 66% of internal appeals were upheld; at least 5,881 external appeals (4% of upheld internal appeals). 2023 KFF survey: 40% believed they had a right to independent/government appeal, 51% unsure.

  • Internal appeals (external link)

    HealthCare.gov · Clinical guideline · Strong evidence

    (2026)

    File within 180 days of a denial; decision within 30 days for services not yet received, 60 days for services already received, and as fast as your condition requires for urgent cases.

  • External review (external link)

    HealthCare.gov · Clinical guideline · Strong evidence

    (2026)

    Request in writing within 4 months of the final internal determination; the insurer is required by law to accept the external reviewer's decision; standard reviews within 45 days, expedited within 72 hours.

Revision history

Last updated · 7 revisions recorded.

Show what changed
  1. v7

    Evidence sources revised

  2. v6

    Common questions revised

  3. v5

    Body revised

  4. v4

    Evidence sources 0 → 3

  5. v3

    Common questions revised

  6. v2

    Summary rewritten; Body revised; Tags updated

  7. v1

    Existing article recorded at the start of version history

Improve this page

Community notes

Share helpful experiences and questions. Notes are reviewed before publication and do not replace medical advice.

Loading notes…

    New submissions are currently paused. Existing approved notes remain available.

    Related guides

    • Escalation paths beyond your insurer: commissioners, ombudsmen, and external review — When your insurer's internal appeals are exhausted, you still have options: independent external review, state regulators, the Department of Labor for self-funded employer plans, and state consumer assistance programs or health insurance advocates. Who does what, and when each applies.
    • Talking to your employer about GLP-1 coverage — Many plans are designed by your employer, not the insurer. This guide covers how to raise GLP-1 coverage with HR or benefits: who to ask, what to ask for, and how to make the case.
    • How to contact your lawmakers about GLP-1 coverage: a step-by-step guide — Congressional staff say individualized contact from constituents sways undecided lawmakers, but most messages leave out what staff find useful. This guide shows how to find your federal and state legislators, match your ask to the right level of government (TROA, the Medicare fix, state mandates, Medicaid), pick a channel, tell your story, and follow up, with a call script and email template.
    • FDA's proposal to keep compounded GLP-1s off the 503B bulks list — and how to comment — In May 2026 the FDA proposed to exclude semaglutide, tirzepatide, and liraglutide from the 503B compounding bulks list, a decision that affects how compounded GLP-1s can be made. The public comment period closed July 30, 2026, and as of late September 2026 the FDA has not published a final determination. This guide explains the proposal, why it matters for access, and what you can still do.
    • Obesity Action Coalition (official site) — The official site of the Obesity Action Coalition, a national patient advocacy nonprofit: education, community support and advocacy resources for people affected by obesity.
    • The Treat and Reduce Obesity Act (H.R. 4231 / S. 1973): what it is and why it matters — TROA is the main federal bill aimed at ending Medicare's exclusion of obesity medications. It was first introduced in 2013 and has been reintroduced with bipartisan support in later Congresses, but it hasn't passed. This guide explains what it would change.